1. Systemic Inflammation-Related Bradycardia in COVID-19
- Author
-
Syed Arshad Raza, Turuvekere Jayaram, Aswin Srinivasan, Branden Wilson, Salman Alim, R.B. Kesavan, Tusharkumar Pansuriya, and S.T. Sarva
- Subjects
Bradycardia ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Sinus bradycardia ,Hemodynamics ,Sequela ,medicine.disease ,Systemic inflammation ,Internal medicine ,RC666-701 ,medicine ,Cardiology ,cardiovascular system ,Diseases of the circulatory (Cardiovascular) system ,Case Series ,cardiovascular diseases ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,circulatory and respiratory physiology - Abstract
Systemic inflammation-related sinus bradycardia in COVID-19 infection has not been well described yet. This six-patient case series excludes common causes of bradycardia. As bradycardia may be a sequela of COVID-19 infection, we recommend closely monitoring hemodynamics and stopping medications that can exacerbate bradycardia in these patients.
- Published
- 2021